Effects of human recombinant PEDF protein and PEDF-derived peptide 34-mer on choroidal neovascularization

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 3, 2010, Pages 1318-1326

  Amaral, Juan ^a   Becerra, S Patricia ^a  

^a NATIONAL EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINE; ASPARTIC ACID; CHYMOTRYPSIN; PIGMENT EPITHELIUM DERIVED FACTOR; POLYPEPTIDE; PROTEIN 34 MER; PROTEIN 44 MER; RECOMBINANT HUMAN PIGMENT EPITHELIUM DERIVED FACTOR; RECOMBINANT PROTEIN; THREONINE; UNCLASSIFIED DRUG; VALINE; EYE PROTEIN; NERVE GROWTH FACTOR; PEPTIDE FRAGMENT; PIGMENT EPITHELIUM-DERIVED FACTOR; SERINE PROTEINASE INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; AORTA; ARTICLE; BRUCH MEMBRANE; CONTROLLED STUDY; EMBRYO; EX VIVO STUDY; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; OPTIC NERVE; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; SUBRETINAL NEOVASCULARIZATION; TISSUE SECTION; ANGIOGENESIS; ANIMAL; BROWN NORWAY RAT; CHICK EMBRYO; CHOROID; CONFOCAL MICROSCOPY; CONJUNCTIVA; DISEASE MODEL; DRUG EFFECT; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; INJECTION; PATHOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; RAT; THORACIC AORTA;

ANIMALS; AORTA, THORACIC; CHICK EMBRYO; CHOROID; CHOROIDAL NEOVASCULARIZATION; CONJUNCTIVA; DISEASE MODELS, ANIMAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EYE PROTEINS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; INJECTIONS; MICROSCOPY, CONFOCAL; NEOVASCULARIZATION, PHYSIOLOGIC; NERVE GROWTH FACTORS; PEPTIDE FRAGMENTS; RATS; RATS, INBRED BN; RECOMBINANT PROTEINS; RETINAL PIGMENT EPITHELIUM; SERPINS;

EID: 77949883008     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-4455     Document Type: Article

References (55)

1. Becerra SP. Focus on molecules: pigment epithelium-derived factor (PEDF). Exp Eye Res. 2006;82:739-740.
2. Filleur S, Nelius T, de Riese W, Kennedy RC. Characterization of PEDF: a multi-functional serpin family protein. J Cell Biochem. 2009;106:769-775.
3. Amaral J, Becerra S. Pigment Epithelium-Derived Factor and Angiogenesis: Therapeutic Implications. Dordrecht, The Netherlands: Springer; 2008;311-337.
4. Bouck N. PEDF: anti-angiogenic guardian of ocular function. Trends Mol Med. 2002;8:330-334.
5. Becerra SP. Structure-function studies on PEDF: a noninhibitory serpin with neurotrophic activity. Adv Exp Med Biol. 1997;425:223-237.
6. Tombran-Tink J, Barnstable CJ. PEDF: a multifaceted neurotrophic factor. Nat Rev. 2003;4:628-636.
7. Holekamp NM, Bouck N, Volpert O. Pigment epithelium-derived factor is deficient in the vitreous of patients with choroidal neo-vascularization due to age-related macular degeneration. Am J Ophthalmol. 2002;134:220-227.
8. Bhutto IA, McLeod DS, Hasegawa T, et al. Pigment epitheliumderived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with age-related macular degeneration. Exp Eye Res. 2006;82:99-110.
9. Ogata N, Nishikawa M, Nishimura T, Mitsuma Y, Matsumura M. Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy. Am J Ophthalmol. 2002;134:348-353.
10. Cao W, Tombran-Tink J, Elias R, Sezate S, Mrazek D, McGinnis JF. In vivo protection of photoreceptors from light damage by pigment epithelium-derived factor. Invest Ophthalmol Vis Sci. 2001;42:1646-1652.
11. Cayouette M, Smith SB, Becerra SP, Gravel C. Pigment epitheliumderived factor delays the death of photoreceptors in mouse models of inherited retinal degenerations. Neurobiol Dis. 1999;6:523-532.
12. Imai D, Yoneya S, Gehlbach PL, Wei LL, Mori K. Intraocular gene transfer of pigment epithelium-derived factor rescues photoreceptors from light-induced cell death. J Cell Physiol. 2005;202:570-578.
13. Miyazaki M, Ikeda Y, Yonemitsu Y, et al. Simian lentiviral vectormediated retinal gene transfer of pigment epithelium-derived factor protects retinal degeneration and electrical defect in Royal College of Surgeons rats. Gene Ther. 2003;10:1503-1511.
14. Duh EJ, Yang HS, Suzuma I, et al. Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth. Invest Ophthalmol Vis Sci. 2002;43:821-829.
15. Mori K, Duh E, Gehlbach P, et al. Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization. J Cell Physiol. 2001;188:253-263.
16. Mori K, Gehlbach P, Ando A, McVey D, Wei L, Campochiaro PA. Regression of ocular neovascularization in response to increased expression of pigment epithelium-derived factor. Invest Ophthalmol Vis Sci. 2002;43:2428-2434.
17. Mori K, Gehlbach P, Yamamoto S, et al. AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization. Invest Ophthalmol Vis Sci. 2002;43:1994-2000.
18. Saishin Y, Silva RL, Saishin Y, et al. Periocular gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization in a human-sized eye. Hum Gene Ther. 2005;16:473-478.
19. Campochiaro PA, Nguyen QD, Shah SM, et al. Adenoviral vectordelivered pigment epithelium-derived factor for neovascular agerelated macular degeneration: results of a phase I clinical trial. Hum Gene Ther. 2006;17:167-176.
20. Apte RS, Barreiro RA, Duh E, Volpert O, Ferguson TA. Stimulation of neovascularization by the anti-angiogenic factor PEDF. Invest Ophthalmol Vis Sci. 2004;45:4491-4497.
21. Steele FR, Chader GJ, Johnson LV, Tombran-Tink J. Pigment epithelium-derived factor: neurotrophic activity and identification as a member of the serine protease inhibitor gene family. Proc Natl Acad Sci USA. 1993;90:1526-1530.
22. Dawson DW, Volpert OV, Gillis P, et al. Pigment epitheliumderived factor: a potent inhibitor of angiogenesis. Science. 1999;285:245-248.
23. Zhang M, Volpert O, Shi YH, Bouck N. Maspin is an angiogenesis inhibitor. Nat Med. 2000;6:196-199.
24. Celerier J, Cruz A, Lamande N, Gasc JM, Corvol P. Angiotensinogen and its cleaved derivatives inhibit angiogenesis. Hypertension. 2002;39:224-228.
25. O'Reilly MS, Pirie-Shepherd S, Lane WS, Folkman J. Antiangiogenic activity of the cleaved conformation of the serpin antithrombin. Science. 1999;285:1926-1928.
26. Simonovic M, Gettins PG, Volz K. Crystal structure of human PEDF, a potent anti-angiogenic and neurite growth-promoting factor. Proc Natl Acad Sci USA. 2001;98:11131-11135.
27. Becerra SP, Sagasti A, Spinella P, Notario V. Pigment epitheliumderived factor behaves like a noninhibitory serpin: neurotrophic activity does not require the serpin reactive loop. J Biol Chem. 1995;270:25992-25999.
28. Alberdi E, Aymerich MS, Becerra SP. Binding of pigment epithelium-derived factor (PEDF) to retinoblastoma cells and cerebellar granule neurons: evidence for a PEDF receptor. J Biol Chem. 1999;274:31605-31612.
29. Alberdi E, Hyde CC, Becerra SP. Pigment epithelium-derived factor (PEDF) binds to glycosaminoglycans: analysis of the binding site. Biochemistry. 1998;37:10643-10652.
30. Meyer C, Notari L, Becerra SP. Mapping the type I collagen-binding site on pigment epithelium-derived factor: Implications for its antiangiogenic activity. J Biol Chem. 2002;277:45400-45407.
31. Aymerich MS, Alberdi EM, Martinez A, Becerra SP. Evidence for pigment epithelium-derived factor receptors in the neural retina. Invest Ophthalmol Vis Sci. 2001;42:3287-3293.
32. Bilak MM, Becerra SP, Vincent AM, Moss BH, Aymerich MS, Kuncl RW. Identification of the neuroprotective molecular region of pigment epithelium-derived factor and its binding sites on motor neurons. J Neurosci. 2002;22:9378-9386.
33. Li H, Tran VV, Hu Y, Mark Saltzman W, Barnstable CJ, Tombran-Tink J. A PEDF N-terminal peptide protects the retina from ischemic injury when delivered in PLGA nanospheres. Exp Eye Res. 2006;83:824-833.
34. Filleur S, Volz K, Nelius T, et al. Two functional epitopes of pigment epithelial-derived factor block angiogenesis and induce differentiation in prostate cancer. Cancer Res. 2005;65:5144-5152.
35. Amaral J, Fariss RN, Campos MM, et al. Transscleral-RPE permeability of PEDF and ovalbumin proteins: implications for subconjunctival protein delivery. Invest Ophthalmol Vis Sci. 2005;46:4383-4392.
36. Demetriades AM, Deering T, Liu H, et al. Trans-scleral delivery of antiangiogenic proteins. J Ocul Pharmacol Ther. 2008;24:70-79.
37. Stratikos E, Alberdi E, Gettins PG, Becerra SP. Recombinant human pigment epithelium-derived factor (PEDF): characterization of PEDF overexpressed and secreted by eukaryotic cells. Protein Sci. 1996;5:2575-2582.
38. Martinez A, Zudaire E, Portal-Nunez S, et al. Proadrenomedullin NH2-terminal 20 peptide is a potent angiogenic factor, and its inhibition results in reduction of tumor growth. Cancer Res. 2004;64:6489-6494.
39. Campos M, Amaral J, Becerra SP, Fariss RN. A novel imaging technique for experimental choroidal neovascularization. Invest Ophthalmol Vis Sci. 2006;47:5163-5170.
40. Dass CR, Tran TM, Choong PF. Angiogenesis inhibitors and the need for anti-angiogenic therapeutics. J Dental Res. 2007;86:927-936.
41. Wahl ML, Kenan DJ, Gonzalez-Gronow M, Pizzo SV. Angiostatin's molecular mechanism: aspects of specificity and regulation elucidated. J Cell Biochem. 2005;96:242-261.
42. Becerra SP, Fariss RN, Wu YQ, Montuenga LM, Wong P, Pfeffer BA. Pigment epithelium-derived factor in the monkey retinal pigment epithelium and interphotoreceptor matrix: apical secretion and distribution. Exp Eye Res. 2004;78:223-234.
43. Karakousis PC, John SK, Behling KC, et al. Localization of pigment epithelium derived factor (PEDF) in developing and adult human ocular tissues. Mol Vis. 2001;7:154-163.
44. Ogata N, Wada M, Otsuji T, Jo N, Tombran-Tink J, Matsumura M. Expression of pigment epithelium-derived factor in normal adult rat eye and experimental choroidal neovascularization. Invest Ophthalmol Vis Sci. 2002;43:1168-1175.
45. Renno RZ, Youssri AI, Michaud N, Gragoudas ES, Miller JW. Expression of pigment epithelium-derived factor in experimental choroidal neovascularization. Invest Ophthalmol Vis Sci. 2002;43:1574-1580.
46. Shi XH, He SZ, Zhao SH. [Expression and signification of pigment epithelium-derived factor in experimental choroidal neovascularization of rat]. [Zhonghua yan ke za zhi]. Chin J Ophthalmol. 2004;40:404-408.
47. Becerra SP, Palmer I, Kumar A, et al. Overexpression of fetal human pigment epithelium-derived factor in Escherichia coli: a functionally active neurotrophic factor. J Biol Chem. 1993;268:23148-23156.
48. Fortier AH, Nelson BJ, Grella DK, Holaday JW. Antiangiogenic activity of prostate-specific antigen. J Natl Cancer Inst. 1999;91:1635-1640.
49. Asanuma K, Yoshikawa T, Hayashi T, et al. Protein C inhibitor inhibits breast cancer cell growth, metastasis and angiogenesis independently of its protease inhibitory activity. Int J Cancer. 2007;121:955-965.
50. Becerra SP, Perez-Mediavilla LA, Weldon JE, et al. Pigment epithelium-derived factor binds to hyaluronan: mapping of a hyaluronan binding site. J Biol Chem. 2008;283:33310-33320.
51. Bernard A, Gao-Li J, Franco CA, Bouceba T, Huet A, Li Z. Laminin receptor involvement in the anti-angiogenic activity of pigment epithelium-derived factor. J Biol Chem. 2009;284:10480-10490.
52. Notari L, Baladron V, Aroca-Aguilar JD, et al. Identification of a lipase-linked cell membrane receptor for pigment epitheliumderived factor. J Biol Chem. 2006;281:38022-38037.
53. Qi JH, Dai G, Luthert P, et al. S156C mutation in tissue inhibitor of metalloproteinases-3 induces increased angiogenesis. J Biol Chem. 2009;284:19927-19936.
54. Mirochnik Y, Aurora A, Schulze-Hoepfner FT, et al. Short pigment epithelial-derived factor-derived peptide inhibits angiogenesis and tumor growth. Clin Cancer Res. 2009;15:1655-1663.
55. Yang H, Akor C, Dithmar S, Grossniklaus HE. Low-dose adjuvant angiostatin decreases hepatic micrometastasis in murine ocular melanoma model. Mol Vis. 2004;10:987-995.